nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—Ketoprofen—CXCR1—ulcerative colitis	0.0933	0.606	CrCbGaD
Alvimopan—Ketoprofen—CXCL8—ulcerative colitis	0.0236	0.153	CrCbGaD
Alvimopan—Indinavir—ABCB1—ulcerative colitis	0.0122	0.0789	CrCbGaD
Alvimopan—Ketoprofen—PTGS1—ulcerative colitis	0.012	0.078	CrCbGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00751	0.00918	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00739	0.00903	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—RIPK2—ulcerative colitis	0.00731	0.00894	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.00711	0.0087	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—CCL20—ulcerative colitis	0.00711	0.00869	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CXCR1—ulcerative colitis	0.0071	0.00868	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00706	0.00863	CbGpPWpGaD
Alvimopan—Ketoprofen—PTGS2—ulcerative colitis	0.00687	0.0446	CrCbGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00659	0.00806	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00658	0.00805	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00644	0.00787	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.00633	0.00775	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00624	0.00763	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CCL20—ulcerative colitis	0.00623	0.00762	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00619	0.00757	CbGpPWpGaD
Alvimopan—Ketoprofen—ALB—ulcerative colitis	0.00612	0.0397	CrCbGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CXCR1—ulcerative colitis	0.006	0.00734	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—CCR6—ulcerative colitis	0.00596	0.00728	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00588	0.00719	CbGpPWpGaD
Alvimopan—OPRM1—Opioid Signalling—ADCY5—ulcerative colitis	0.00586	0.00717	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00569	0.00696	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00565	0.00691	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00564	0.0069	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00557	0.00681	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00556	0.0068	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.00555	0.00679	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00553	0.00676	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CCL20—ulcerative colitis	0.00527	0.00644	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00523	0.0064	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CCR6—ulcerative colitis	0.00522	0.00639	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00516	0.0063	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00504	0.00616	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00499	0.0061	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00496	0.00606	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CXCR1—ulcerative colitis	0.0049	0.00599	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00487	0.00595	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00485	0.00593	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00477	0.00583	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00474	0.00579	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.00469	0.00574	CbGpPWpGaD
Alvimopan—OPRM1—IL4-mediated signaling events—JAK2—ulcerative colitis	0.00453	0.00553	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00442	0.0054	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CCR6—ulcerative colitis	0.00441	0.0054	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00436	0.00533	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CCL20—ulcerative colitis	0.0043	0.00526	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CXCR1—ulcerative colitis	0.0043	0.00526	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00427	0.00522	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00422	0.00516	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00419	0.00512	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00417	0.0051	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00415	0.00508	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.0041	0.00501	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CXCR2—ulcerative colitis	0.00384	0.00469	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00382	0.00467	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCL20—ulcerative colitis	0.00377	0.00461	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00373	0.00456	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.00369	0.00451	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00366	0.00447	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CXCR1—ulcerative colitis	0.00363	0.00444	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00361	0.00441	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CCR6—ulcerative colitis	0.00361	0.00441	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00351	0.00429	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.00337	0.00412	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CXCR2—ulcerative colitis	0.00336	0.00411	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00335	0.00409	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—RELA—ulcerative colitis	0.00325	0.00398	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.00323	0.00395	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCL20—ulcerative colitis	0.00319	0.0039	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—CD4—ulcerative colitis	0.00318	0.00389	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—PTGER4—ulcerative colitis	0.00317	0.00388	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCR6—ulcerative colitis	0.00316	0.00387	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00316	0.00386	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00309	0.00378	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.00296	0.00362	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—IL1B—ulcerative colitis	0.00294	0.0036	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—GHRL—ulcerative colitis	0.00291	0.00355	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CXCR2—ulcerative colitis	0.00284	0.00348	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00283	0.00346	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—PTGER4—ulcerative colitis	0.00278	0.0034	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00277	0.00339	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.00277	0.00339	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—NFKB1—ulcerative colitis	0.00274	0.00335	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.00273	0.00334	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCR6—ulcerative colitis	0.00267	0.00327	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—GHRL—ulcerative colitis	0.00255	0.00312	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCR1—ulcerative colitis	0.00252	0.00308	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.0025	0.00306	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CCL20—ulcerative colitis	0.00243	0.00297	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.00243	0.00297	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—ADRB2—ulcerative colitis	0.00241	0.00294	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—PTGER4—ulcerative colitis	0.00235	0.00288	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00234	0.00286	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—GNA12—ulcerative colitis	0.00229	0.0028	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—TGFB1—ulcerative colitis	0.00229	0.00279	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.00228	0.00278	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL20—ulcerative colitis	0.00221	0.0027	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCR1—ulcerative colitis	0.00221	0.0027	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.00217	0.00265	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—GHRL—ulcerative colitis	0.00215	0.00263	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCL20—ulcerative colitis	0.00213	0.00261	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—ADRB2—ulcerative colitis	0.00211	0.00258	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—GNA12—ulcerative colitis	0.00208	0.00254	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.00205	0.00251	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CCR6—ulcerative colitis	0.00204	0.00249	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—GNA12—ulcerative colitis	0.002	0.00245	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.00199	0.00244	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCR2—ulcerative colitis	0.00197	0.00241	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL20—ulcerative colitis	0.00194	0.00237	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.00192	0.00235	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.0019	0.00232	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCR1—ulcerative colitis	0.00186	0.00228	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCR6—ulcerative colitis	0.00185	0.00226	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—GNA12—ulcerative colitis	0.00182	0.00223	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SEL1L—ulcerative colitis	0.0018	0.00221	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCL20—ulcerative colitis	0.0018	0.0022	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00179	0.00219	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCR6—ulcerative colitis	0.00179	0.00219	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—ADRB2—ulcerative colitis	0.00178	0.00218	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCR2—ulcerative colitis	0.00173	0.00211	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—IL6—ulcerative colitis	0.00172	0.00211	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—GNA12—ulcerative colitis	0.00169	0.00207	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.00169	0.00206	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.00168	0.00206	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—GHRL—ulcerative colitis	0.00164	0.00201	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL20—ulcerative colitis	0.00164	0.002	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PTGER4—ulcerative colitis	0.00163	0.00199	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCR6—ulcerative colitis	0.00162	0.00198	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.00161	0.00196	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SEL1L—ulcerative colitis	0.00158	0.00193	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00157	0.00192	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—GNA12—ulcerative colitis	0.00154	0.00188	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.00153	0.00187	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCR6—ulcerative colitis	0.00151	0.00185	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—GHRL—ulcerative colitis	0.00149	0.00182	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCR1—ulcerative colitis	0.00149	0.00182	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCR2—ulcerative colitis	0.00146	0.00178	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CALM3—ulcerative colitis	0.00144	0.00177	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—GHRL—ulcerative colitis	0.00144	0.00176	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PTGER4—ulcerative colitis	0.00143	0.00175	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.00142	0.00174	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCR6—ulcerative colitis	0.00137	0.00168	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00136	0.00166	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.00134	0.00164	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SEL1L—ulcerative colitis	0.00134	0.00164	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00133	0.00163	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—GHRL—ulcerative colitis	0.00131	0.0016	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL20—ulcerative colitis	0.0013	0.0016	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCR1—ulcerative colitis	0.0013	0.00159	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CALM3—ulcerative colitis	0.00127	0.00155	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—ADRB2—ulcerative colitis	0.00123	0.00151	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—GNA12—ulcerative colitis	0.00123	0.0015	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—GHRL—ulcerative colitis	0.00122	0.00149	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PTGER4—ulcerative colitis	0.00121	0.00148	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00119	0.00146	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCR2—ulcerative colitis	0.00116	0.00142	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CXCL8—ulcerative colitis	0.00116	0.00142	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00115	0.00141	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL20—ulcerative colitis	0.00114	0.0014	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.00113	0.00138	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—GHRL—ulcerative colitis	0.00111	0.00135	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCR1—ulcerative colitis	0.0011	0.00135	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCR6—ulcerative colitis	0.00109	0.00134	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—ADRB2—ulcerative colitis	0.00108	0.00132	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GNA12—ulcerative colitis	0.00108	0.00132	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CALM3—ulcerative colitis	0.00107	0.00131	CbGpPWpGaD
Alvimopan—Hypokalaemia—Budesonide—ulcerative colitis	0.00107	0.0379	CcSEcCtD
Alvimopan—Malnutrition—Mercaptopurine—ulcerative colitis	0.00106	0.0376	CcSEcCtD
Alvimopan—OPRD1—Signaling by GPCR—ADCY5—ulcerative colitis	0.00105	0.00128	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MAML2—ulcerative colitis	0.00104	0.00127	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCR2—ulcerative colitis	0.00102	0.00125	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CXCL8—ulcerative colitis	0.00102	0.00125	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00101	0.00124	CbGpPWpGaD
Alvimopan—Flatulence—Nicotine—ulcerative colitis	0.00101	0.0359	CcSEcCtD
Alvimopan—OPRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00101	0.00123	CbGpPWpGaD
Alvimopan—Back pain—Nicotine—ulcerative colitis	0.000993	0.0352	CcSEcCtD
Alvimopan—Anaemia—Mercaptopurine—ulcerative colitis	0.000979	0.0347	CcSEcCtD
Alvimopan—OPRM1—Signaling Pathways—CCL20—ulcerative colitis	0.000967	0.00118	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PTGER4—ulcerative colitis	0.000962	0.00118	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCR6—ulcerative colitis	0.000959	0.00117	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000919	0.00112	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000915	0.00112	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GNA12—ulcerative colitis	0.000909	0.00111	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MAML2—ulcerative colitis	0.000909	0.00111	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—GHRL—ulcerative colitis	0.000881	0.00108	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCR2—ulcerative colitis	0.000862	0.00105	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000861	0.00105	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000855	0.00105	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CALM3—ulcerative colitis	0.000853	0.00104	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PTGER4—ulcerative colitis	0.000844	0.00103	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RIPK2—ulcerative colitis	0.000841	0.00103	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR6—ulcerative colitis	0.00081	0.000991	CbGpPWpGaD
Alvimopan—Urinary tract disorder—Budesonide—ulcerative colitis	0.000802	0.0284	CcSEcCtD
Alvimopan—Connective tissue disorder—Budesonide—ulcerative colitis	0.000798	0.0283	CcSEcCtD
Alvimopan—Urethral disorder—Budesonide—ulcerative colitis	0.000796	0.0282	CcSEcCtD
Alvimopan—OPRM1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000777	0.00095	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GHRL—ulcerative colitis	0.000773	0.000945	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MAML2—ulcerative colitis	0.000768	0.000939	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CALM3—ulcerative colitis	0.000748	0.000915	CbGpPWpGaD
Alvimopan—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000746	0.0265	CcSEcCtD
Alvimopan—Dyspepsia—Nicotine—ulcerative colitis	0.000737	0.0262	CcSEcCtD
Alvimopan—OPRK1—Signaling Pathways—RIPK2—ulcerative colitis	0.000737	0.000901	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ADRB2—ulcerative colitis	0.000729	0.000892	CbGpPWpGaD
Alvimopan—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000723	0.0256	CcSEcCtD
Alvimopan—OPRD1—GPCR downstream signaling—JAK2—ulcerative colitis	0.00072	0.00088	CbGpPWpGaD
Alvimopan—Constipation—Nicotine—ulcerative colitis	0.000716	0.0254	CcSEcCtD
Alvimopan—OPRM1—Signaling Pathways—PTGER4—ulcerative colitis	0.000713	0.000872	CbGpPWpGaD
Alvimopan—Malnutrition—Budesonide—ulcerative colitis	0.000707	0.0251	CcSEcCtD
Alvimopan—Flatulence—Budesonide—ulcerative colitis	0.000696	0.0247	CcSEcCtD
Alvimopan—Back pain—Budesonide—ulcerative colitis	0.000684	0.0242	CcSEcCtD
Alvimopan—OPRD1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000657	0.000803	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—JAK2—ulcerative colitis	0.000653	0.000799	CbGpPWpGaD
Alvimopan—Anaemia—Budesonide—ulcerative colitis	0.000653	0.0232	CcSEcCtD
Alvimopan—OPRM1—Signaling Pathways—GHRL—ulcerative colitis	0.000653	0.000799	CbGpPWpGaD
Alvimopan—Urinary tract disorder—Mesalazine—ulcerative colitis	0.000652	0.0231	CcSEcCtD
Alvimopan—Connective tissue disorder—Mesalazine—ulcerative colitis	0.000649	0.023	CcSEcCtD
Alvimopan—Urethral disorder—Mesalazine—ulcerative colitis	0.000647	0.023	CcSEcCtD
Alvimopan—OPRK1—Signaling Pathways—ADRB2—ulcerative colitis	0.00064	0.000782	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CALM3—ulcerative colitis	0.000632	0.000773	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000631	0.000772	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—IL2—ulcerative colitis	0.000628	0.000767	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RIPK2—ulcerative colitis	0.000623	0.000762	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ADCY5—ulcerative colitis	0.000619	0.000757	CbGpPWpGaD
Alvimopan—Hypokalaemia—Hydrocortisone—ulcerative colitis	0.000618	0.0219	CcSEcCtD
Alvimopan—OPRD1—Signaling by GPCR—CXCL8—ulcerative colitis	0.000596	0.000729	CbGpPWpGaD
Alvimopan—Anaemia—Azathioprine—ulcerative colitis	0.000583	0.0207	CcSEcCtD
Alvimopan—OPRK1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000576	0.000704	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—JAK2—ulcerative colitis	0.000573	0.000701	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL2—ulcerative colitis	0.00057	0.000697	CbGpPWpGaD
Alvimopan—Flatulence—Mesalazine—ulcerative colitis	0.000566	0.0201	CcSEcCtD
Alvimopan—Back pain—Mesalazine—ulcerative colitis	0.000556	0.0197	CcSEcCtD
Alvimopan—OPRK1—GPCR downstream signaling—IL2—ulcerative colitis	0.00055	0.000673	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ADCY5—ulcerative colitis	0.000543	0.000664	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADRB2—ulcerative colitis	0.000541	0.000661	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000533	0.000652	CbGpPWpGaD
Alvimopan—Anaemia—Mesalazine—ulcerative colitis	0.000531	0.0188	CcSEcCtD
Alvimopan—Hypokalaemia—Dexamethasone—ulcerative colitis	0.000528	0.0187	CcSEcCtD
Alvimopan—Hypokalaemia—Betamethasone—ulcerative colitis	0.000528	0.0187	CcSEcCtD
Alvimopan—OPRK1—Signaling by GPCR—CXCL8—ulcerative colitis	0.000523	0.000639	CbGpPWpGaD
Alvimopan—Dyspepsia—Budesonide—ulcerative colitis	0.000508	0.018	CcSEcCtD
Alvimopan—OPRK1—Signaling by GPCR—IL2—ulcerative colitis	0.0005	0.000611	CbGpPWpGaD
Alvimopan—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000498	0.0177	CcSEcCtD
Alvimopan—Constipation—Budesonide—ulcerative colitis	0.000493	0.0175	CcSEcCtD
Alvimopan—OPRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000487	0.000595	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—JAK2—ulcerative colitis	0.000484	0.000592	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—IL2—ulcerative colitis	0.000465	0.000569	CbGpPWpGaD
Alvimopan—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000461	0.0164	CcSEcCtD
Alvimopan—Hypokalaemia—Prednisone—ulcerative colitis	0.00046	0.0163	CcSEcCtD
Alvimopan—OPRM1—Signaling Pathways—ADCY5—ulcerative colitis	0.000459	0.000561	CbGpPWpGaD
Alvimopan—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000445	0.0158	CcSEcCtD
Alvimopan—OPRM1—Signaling by GPCR—CXCL8—ulcerative colitis	0.000442	0.00054	CbGpPWpGaD
Alvimopan—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000433	0.0154	CcSEcCtD
Alvimopan—OPRM1—Signaling by GPCR—IL2—ulcerative colitis	0.000422	0.000516	CbGpPWpGaD
Alvimopan—Dyspepsia—Mesalazine—ulcerative colitis	0.000413	0.0146	CcSEcCtD
Alvimopan—Malnutrition—Hydrocortisone—ulcerative colitis	0.000409	0.0145	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000405	0.0144	CcSEcCtD
Alvimopan—Constipation—Mesalazine—ulcerative colitis	0.000401	0.0142	CcSEcCtD
Alvimopan—OPRD1—Signaling Pathways—JAK2—ulcerative colitis	0.000386	0.000472	CbGpPWpGaD
Alvimopan—Malnutrition—Methylprednisolone—ulcerative colitis	0.000384	0.0136	CcSEcCtD
Alvimopan—OPRD1—Signaling Pathways—RELA—ulcerative colitis	0.000374	0.000457	CbGpPWpGaD
Alvimopan—Back pain—Triamcinolone—ulcerative colitis	0.000372	0.0132	CcSEcCtD
Alvimopan—OPRD1—Signaling Pathways—CXCL8—ulcerative colitis	0.000352	0.000431	CbGpPWpGaD
Alvimopan—Connective tissue disorder—Prednisone—ulcerative colitis	0.000343	0.0122	CcSEcCtD
Alvimopan—OPRK1—Signaling Pathways—JAK2—ulcerative colitis	0.000338	0.000414	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL2—ulcerative colitis	0.000337	0.000412	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL6—ulcerative colitis	0.000335	0.00041	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RELA—ulcerative colitis	0.000328	0.000401	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MMP9—ulcerative colitis	0.000319	0.00039	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NFKB1—ulcerative colitis	0.000315	0.000386	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL8—ulcerative colitis	0.000309	0.000378	CbGpPWpGaD
Alvimopan—Malnutrition—Prednisone—ulcerative colitis	0.000304	0.0108	CcSEcCtD
Alvimopan—OPRK1—Signaling Pathways—IL2—ulcerative colitis	0.000295	0.000361	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6—ulcerative colitis	0.000294	0.000359	CbGpPWpGaD
Alvimopan—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000294	0.0104	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000288	0.0102	CcSEcCtD
Alvimopan—OPRM1—Signaling Pathways—JAK2—ulcerative colitis	0.000286	0.00035	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—STAT3—ulcerative colitis	0.000283	0.000346	CbGpPWpGaD
Alvimopan—Anaemia—Prednisone—ulcerative colitis	0.000281	0.00997	CcSEcCtD
Alvimopan—OPRK1—Signaling Pathways—MMP9—ulcerative colitis	0.000279	0.000342	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RELA—ulcerative colitis	0.000277	0.000339	CbGpPWpGaD
Alvimopan—Dyspepsia—Triamcinolone—ulcerative colitis	0.000276	0.00981	CcSEcCtD
Alvimopan—OPRK1—Signaling Pathways—NFKB1—ulcerative colitis	0.000276	0.000338	CbGpPWpGaD
Alvimopan—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000276	0.00979	CcSEcCtD
Alvimopan—OPRD1—Signaling Pathways—TGFB1—ulcerative colitis	0.000263	0.000321	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL8—ulcerative colitis	0.000261	0.000319	CbGpPWpGaD
Alvimopan—Dyspepsia—Betamethasone—ulcerative colitis	0.000251	0.0089	CcSEcCtD
Alvimopan—Dyspepsia—Dexamethasone—ulcerative colitis	0.000251	0.0089	CcSEcCtD
Alvimopan—OPRM1—Signaling Pathways—IL2—ulcerative colitis	0.00025	0.000305	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—STAT3—ulcerative colitis	0.000248	0.000304	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6—ulcerative colitis	0.000248	0.000304	CbGpPWpGaD
Alvimopan—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000246	0.00873	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000246	0.00873	CcSEcCtD
Alvimopan—OPRM1—Signaling Pathways—MMP9—ulcerative colitis	0.000236	0.000289	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NFKB1—ulcerative colitis	0.000234	0.000286	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TGFB1—ulcerative colitis	0.00023	0.000282	CbGpPWpGaD
Alvimopan—Dyspepsia—Prednisone—ulcerative colitis	0.000218	0.00775	CcSEcCtD
Alvimopan—OPRD1—Signaling Pathways—TP53—ulcerative colitis	0.000216	0.000264	CbGpPWpGaD
Alvimopan—Constipation—Prednisone—ulcerative colitis	0.000212	0.00753	CcSEcCtD
Alvimopan—OPRM1—Signaling Pathways—STAT3—ulcerative colitis	0.00021	0.000257	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6—ulcerative colitis	0.000198	0.000242	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TGFB1—ulcerative colitis	0.000195	0.000238	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TP53—ulcerative colitis	0.00019	0.000232	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6—ulcerative colitis	0.000174	0.000212	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TP53—ulcerative colitis	0.00016	0.000196	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6—ulcerative colitis	0.000147	0.000179	CbGpPWpGaD
